Back
Dr. Reddy's Laboratories Ltd. 10K Form
Sell
20
RDY
Dr. Reddy's Laboratories Ltd.
Last Price:
$13.42
Seasonality Move:
2.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RDY News And Ratings
See the #1 stock for the next 7 days that we like better than RDY
RDY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.9B |
|---|---|
| Cash Flow: | $32.9M |
| Price / Cash Flow: | 68.29 |
| Annual Sales: | $4.96 |
| Price / Book: | 2.7 |
Profitability
| EPS (TTM): | 0.77890 |
|---|---|
| Net Income (TTM): | $644.9M |
| Gross Margin: | $2.1B |
| Return on Equity: | 15.8% |
| Return on Assets: | 10.66% |
Dr. Reddy's Laboratories Ltd. Earnings Forecast
Key Dr. Reddy's Laboratories Ltd. Financial Ratios
-
The Gross Profit Margin over the past 32 years for RDY is 55.44%.
-
The Selling, General & Administrative Expenses for RDY have been equal to 28.84% of Gross Profit Margin.
-
The Research & Development expenses have been 8.00% of Revenue.
-
The Interest Expense is 4.94% of Operating Income.
-
The Net Earning history of RDY is 17.58% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 14 years.
Dr. Reddy's Laboratories Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RDY |
| CUSIP: | 256135 |
| Website: | drreddys.com |
Debt
| Debt-to-Equity Ratio: | 0.18 |
|---|---|
| Current Ratio: | 1.88 |
| Quick Ratio: | 1.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 16.74 |
|---|---|
| Forward P/E Ratio: | 23.72 |
RDY Technical Analysis vs Fundamental Analysis
Sell
20
Dr. Reddy's Laboratories Ltd. (RDY)
is a Sell
Is Dr. Reddy's Laboratories Ltd. a Buy or a Sell?
-
Dr. Reddy's Laboratories Ltd. stock is rated a SellThe current Dr. Reddy's Laboratories Ltd. [RDY] share price is $13.42. The Score for RDY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.